CD57 Antikörper (AA 1-200)
Kurzübersicht für CD57 Antikörper (AA 1-200) (ABIN7868390)
Target
Alle CD57 (B3GAT1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 1-200
-
Verwendungszweck
- CD57 Antibody / HNK-1 (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A recombinant partial protein (within amino acids 1-200) from the human protein was used as the immunogen for the CD57 antibody.
-
Isotyp
- IgG2, lambda
-
-
-
-
Applikationshinweise
- Optimal dilution of the CD57 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the CD57 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
-
Andere Bezeichnung
- CD57
-
Hintergrund
- Anti-CD57 marks a subset of lymphocytes known as natural killer (NK) cells. Follicular center cell lymphomas often contain many NK cells within the neoplastic follicles. Anti-CD57 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor and medulloblastoma. Anti-CD57 can also be useful in separating type B3 thymoma from thymic carcinoma when combined with a panel that includes antibodies against GLUT1, CD5, and CEA.
-
UniProt
- Q9P2W7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-